These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7830403)

  • 21. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. alpha beta T cell receptor-positive intraepithelial lymphocytes with CD4+, CD8- and CD4+, CD8+ phenotypes from orally immunized mice provide Th2-like function for B cell responses.
    Fujihashi K; Yamamoto M; McGhee JR; Kiyono H
    J Immunol; 1993 Dec; 151(12):6681-91. PubMed ID: 7903096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effector activity of decidual CD8+ T lymphocytes in early human pregnancy.
    Scaife PJ; Bulmer JN; Robson SC; Innes BA; Searle RF
    Biol Reprod; 2006 Oct; 75(4):562-7. PubMed ID: 16822900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent in vivo anti-tumor activity of isolated CD62L(low) lymph node cells sensitized in vivo with tumor lysate-pulsed DC-based vaccines.
    Liu Z; Fan H; Wu Y; Chen B
    Cytotherapy; 2005; 7(4):353-62. PubMed ID: 16162457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of CD8+ murine T cells from tumor-draining lymph nodes by phorbol dibutyrate plus calcium ionophore.
    Tuttle TM; Inge TH; McCrady CM; Bethke KP; Bear HD
    J Immunother (1991); 1992 Jul; 12(1):32-40. PubMed ID: 1386251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complete elimination ('cure') of progressively growing intraocular tumors by local injection of tumor-specific CD8+ T lymphocytes.
    Miki S; Ksander B; Streilein JW
    Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3622-34. PubMed ID: 8258521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experimental study of anti-tumor immunologic response induced by cryoablation for prostate cancer].
    Guo XY; Si TG; Guo Z; Wang HT
    Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(14):952-5. PubMed ID: 20646642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sampling tumor-draining lymph nodes for phenotypic and functional analysis of dendritic cells and T cells.
    Vuylsteke RJ; van Leeuwen PA; Meijer S; Wijnands PG; Statius Muller MG; Busch DH; Scheper RJ; de Gruijl TD
    Am J Pathol; 2002 Jul; 161(1):19-26. PubMed ID: 12107085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. II. Cytokine production and in vivo efficacy of glioma-sensitized lymphocytes.
    Rice CD; Baldwin NG; Biron RT; Bear HD; Merchant RE
    J Neurooncol; 1997 Mar; 32(1):29-38. PubMed ID: 9049860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation and expansion of cytotoxic T lymphocytes from tumor-draining lymph nodes.
    McKinnon JG; Hoover SK; Inge TH; Bear HD
    Cancer Immunol Immunother; 1990; 32(1):38-44. PubMed ID: 2126983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in cytokine levels and CD4+/CD8+ T cells ratio in draining lymph node of burn wound.
    Wang K; Wang DC; Feng YQ; Xiang-Feng L
    J Burn Care Res; 2007; 28(5):747-53. PubMed ID: 17667489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional analysis of mononuclear cells infiltrating into tumors. V. A. soluble factor involved in the regulation of cytotoxic/suppressor T cell infiltration into tumors.
    Shijubo N; Uede T; Kikuchi K
    J Immunol; 1989 Apr; 142(8):2961-7. PubMed ID: 2522972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes.
    Bos R; Sherman LA
    Cancer Res; 2010 Nov; 70(21):8368-77. PubMed ID: 20940398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation and in vitro expansion of tumor-reactive T lymphocytes from lymph nodes draining human primary breast cancers.
    Hoover SK; Frank JL; McCrady C; McKinnon JG; Bear HD
    J Surg Oncol; 1991 Feb; 46(2):117-24. PubMed ID: 1825123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. I. Characterization and in vivo anti-tumor activity of glioma-sensitized lymphocytes.
    Baldwin NG; Rice CD; Tuttle TM; Bear HD; Hirsch JI; Merchant RE
    J Neurooncol; 1997 Mar; 32(1):19-28. PubMed ID: 9049859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic shifts in the L5178Y lymphoma population during progression of the tumor-dormant state in DBA/2 mice.
    Trainer DL; Wheelock EF
    Cancer Res; 1984 Mar; 44(3):1063-71. PubMed ID: 6607108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-cell analysis of cytotoxic T cell function by intravital multiphoton microscopy.
    Mempel TR
    Methods Mol Biol; 2010; 616():181-92. PubMed ID: 20379876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phorbol dibutyrate plus ionomycin improves the generation of cytotoxic T cells from draining lymph nodes of patients with advanced head and neck cancer.
    McGrath PC; Hamby LS; Freeman JW
    Am J Surg; 1992 Dec; 164(6):610-4. PubMed ID: 1463110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bryostatin 1 activates T cells that have antitumor activity.
    Tuttle TM; Inge TH; Wirt CP; Frank JL; McCrady CM; Bear HD
    J Immunother (1991); 1992 Aug; 12(2):75-81. PubMed ID: 1504056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.